The tumour was called ‘SMARACA4‐deficient thoracic sarcoma’ (SMARCA4‐DTS) until recently, but the currently recommended terminology is SMARCA4‐UT according to the 2021 World Health Organization (WHO) classification of thoracic tumours.1 The gene discussed is SMARCA4; the disease is neoplasm.